Baum, Hedlund, Aristei & Goldman
Recent News About Baum, Hedlund, Aristei & Goldman
-
Appeals court refuses to reinstate $3M verdict for widow, who sued GSK over husband’s suicide
The woman's lawyers had claimed GSK never fully updated warning labels for its antidepressant Paxil to reflect true suicide risk. -
Lawyer's widow: Recent Supreme Court ruling means she should get $3M in lawsuit vs drugmaker GSK over Paxil labeling
SCOTUS ruling changed "approach" to drug labeling questions, plaintiffs said. GSK says the change wasn't "extraordinary" enough and would open "floodgates" to attempts at lawsuit "do-overs." -
Widow asks federal judge to reinstate $3M verdict vs GSK in suicide suit, despite SCOTUS appeal rejection
In the wake of the U.S. Supreme Court’s recent refusal to hear her case, the widow of a Chicago man, who killed himself after allegedly taking the generic form of the antidepressant Paxil, is trying to have a federal district judge restore her $3 million verdict against drugmaker GSK, because the company allegedly didn’t push federal regulators to revise the drug’s warning label. -
SCOTUS decision could mean new hearing for widow's suit vs GSK over suicide of lawyer taking generic Paxil
A federal appeals court in Chicago could be tasked with taking another look at its previous decision undoing a jury verdict ordering drug maker GSK to pay $3 million to the widow of a Chicago lawyer who committed suicide after taking the generic equivalent of a widely prescribed antidepressant drug.